Get started

Moderna

MRNA Moderna vaccine 94.5% effective in Phase 3 trial!This was my previews post about Moderna: The indicators are still bullish. The price of the stock grew 5X since the beginning of the year. 11/16/2020 Oppenheimer Boost Price Target ➝ $157.00 11/16/2020 Piper Sandler Boost Price Target ➝ $166.00 The traditional method of creating vaccines – introducing a weakened or dead virus, or a piece of one, to stimulate the body's immune system – takes over a decade on average, according to a 2013 study. One pandemic flu vaccine took over eight years while a hepatitis B vaccine was nearly 18 years in the making. Moderna's vaccine went from gene sequencing to the first human injection in 63 days. Moderna and BioNTech, for example, are also applying mRNA technology to experimental cancer medicines. BioNTech's vaccine, for example, must be transported at minus 70 degrees Celsius, though Moderna said on Monday it can ship its candidate in normal refrigerators. (Reuters) If you are interested to test some amazing BUY and SELL INDICATORS, which give the signal at the beginning of the candle, not at the end of it, just leave me a message.
NASDAQ:MRNALong
by TopgOptions
My two cents on my most profitable traded stock this year, MRNAI have traded MRNA more than any other stock. Even if you lack the experience and know-how of trading, following some basics trends will give you a high winning percentage with this stock. 1) Finding the premarket high and shorting the stock close to that gives you about an 85% chance of a 50cent-$1 move before market opens. 2) A lot of the news on this stock is old and reused. Today for example there is news that seniors exhibit very few health issues with the stock. This is old news. 3) With every single run up including the first major one close to $100 a few months back, MRNA has flushed 100% of the time with no ability to maintain the premarket levels.
NASDAQ:MRNAShort
by cazmuh
Is MRNA revealing major upside opportunity? BULL or BEAR? Today we're looking at MRNA aka Moderna, the darling biotech that might be the savior of us all should they produce an mRNA vaccine that could be more easily produced and distributed at scale than a traditional vaccine candidate. Reading into this story I've been intrigued, especially with the nice patterns forming in this chart with an easy to identify Impulse wave and a correction pattern currently forming. Unfortunately, this is always the riskier proposition and we must consider our Bull and Bear cases objectively so that we have a plan. As you'll see, we recently bounced off the 0.5 fib retracement from the all-time high of $95 all the way back to $53. Looks like a healthy bounce off that level. But we should almost always expect it. There is nothing to get excited about until we see a more convincing bounce with volume. While I love the long term pattern being set up in this chart with that hopeful bull target of $136.99, there's a lot of work to make up and resistance to overcome before we get anywhere close. The declining volume is something to watch out for. If you zoom in you'll see the upward channel off the bounce paired with the declining volume. This would indicate that short term we'll retest the low, and if we're lucky we can get a buying opportunity off that low and off the 0.618 at $43.50. Set your ladders appropriately and always calculate your stop loss according to risk preference fo % loss below average calculated cost. If you plan your buy levels and amount in advance you can easily calculate the average buy price and then subtract 20% for example to reach a reasonable stop loss which shields you from setting a stop loss too high and missing the following run, or setting it too low and losing more than you are willing to. Meanwhile, looking at the long term trend, we'll have some trading potential on the stock, but need to look for some volatility within the current correction pattern. Given the sharp increase and resulting decrease, one can assume we might see similar moves again in the future, though there's nothing to indicate exactly when at the moment until we see a better channel or a convincing wedge reveal itself. The longer-term trend bodes well for your everyday investor who's willing to take some loss for a very large potential gain. Should Moderna create their mRNA based vaccine in time and be successful with distribution, the value of this company would quickly skyrocket. I'm willing to bet on an optimistic future and I'm definitely keeping an eye on this opportunity with the buy ladders I've mentioned indicated. What's your Bull and Bear case on Moderna? How would you play this in the short and long term?
NASDAQ:MRNA
by Shadowfigure
2
Moderna Stock Analysis - MRNAModerna (NASDAQ: MRNA). The Major trend is Bullish; The Trendline and EMA (with a length of 200) has been broken giving a signal of weakness of this Market. The idea is always to invest in the trend direction (bullish), but currently there are not a lot of signals to go long. If 66.5 USD level will not be broken in the next days, perhaps the idea is to go long, or, vice versa, if the support will be broken the idea is to go short (this option is too Risky).
NASDAQ:MRNALong
by Mauriello
2